To examine the clinical relevance of ZNF32 and GPER expression in breast cancers, we measured the expression of GPER and ALDH1 in ZNF32-high or ZNF32-low expression breast cancer samples using IHC. The gene discussed is GPER1; the disease is breast cancer.